Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Igor Kadet
Business Development Associate
igor.kadet@gero.ai

Message the company or request a 1:1 meeting here

Gero is the next-gen AI drug discovery company utilizing real-world big clinical, genetic (WES), and molecular data from vast human cohorts instead of animal models to help our partners create revolutionary medicines against complex diseases.

According to the research, the genetic link between target and disease increases the chances of passing the Phase II clinical trial almost twice. At Gero, we know how to do drug discovery from Whole-Exome Sequencing data to rapidly discover novel targets in human data and improve clinical trial success much more than that. We identify cause and effect relationships between mutations, disease progression models, targets, and drugs related to them.

Pitch Video

Executive Summary